インターフェロンγ
(IFN‐γ から転送)
出典: フリー百科事典『ウィキペディア(Wikipedia)』 (2022/05/20 00:14 UTC 版)
インターフェロンγ(英: interferon gamma、略称: IFN-γ)は、二量体型可溶性サイトカインであり、II型インターフェロンの唯一のメンバーである[5]。このインターフェロンは当初は免疫インターフェロン(immune interferon)と呼ばれており、E. F. Wheelockによってフィトヘマグルチニン刺激を受けたヒト白血球による産物として記載された[6]。また抗原刺激されたヒトリンパ球[7]やツベルクリン感作マウス腹膜リンパ球[8]でも産生されることが示され、水疱性口内炎ウイルスの増殖を阻害することが示された。こうした報告には、現在結核の検査に広く用いられているIFN-γ遊離試験の基礎をなす観察が含まれていた。ヒトでは、IFN-γタンパク質はIFNG遺伝子によってコードされる[9][10]。
- ^ a b c GRCh38: Ensembl release 89: ENSG00000111537 - Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000055170 - Ensembl, May 2017
- ^ Human PubMed Reference:
- ^ Mouse PubMed Reference:
- ^ “Structure of the human immune interferon gene”. Nature 298 (5877): 859–863. (August 1982). Bibcode: 1982Natur.298..859G. doi:10.1038/298859a0. PMID 6180322.
- ^ “Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin”. Science 149 (3681): 310–311. (July 1965). Bibcode: 1965Sci...149..310W. doi:10.1126/science.149.3681.310. PMID 17838106.
- ^ “Immune specific induction of interferon production in cultures of human blood lymphocytes”. Science 164 (3886): 1415–1417. (June 1969). Bibcode: 1969Sci...164.1415G. doi:10.1126/science.164.3886.1415. PMID 5783715.
- ^ “Release of virus inhibitor from tuberculin-sensitized peritoneal cells stimulated by antigen”. Journal of Immunology 105 (5): 1068–1071. (November 1970). PMID 4321289.
- ^ “Human immune interferon gene is located on chromosome 12”. The Journal of Experimental Medicine 157 (3): 1020–1027. (March 1983). doi:10.1084/jem.157.3.1020. PMC 2186972. PMID 6403645 .
- ^ a b “IFNG interferon gamma [Homo sapiens (human) - Gene - NCBI]”. www.ncbi.nlm.nih.gov. 2022年4月16日閲覧。
- ^ “Regulation of Interferon‐γ During Innate and Adaptive Immune Responses”. Regulation of interferon-gamma during innate and adaptive immune responses. 96. (2007). 41–101. doi:10.1016/S0065-2776(07)96002-2. ISBN 978-0-12-373709-0. PMID 17981204
- ^ “The biology of innate lymphoid cells”. Nature 517 (7534): 293–301. (January 2015). Bibcode: 2015Natur.517..293A. doi:10.1038/nature14189. PMID 25592534.
- ^ “Three-dimensional structure of recombinant human interferon-gamma”. Science 252 (5006): 698–702. (May 1991). Bibcode: 1991Sci...252..698E. doi:10.1126/science.1902591. PMID 1902591.
- ^ a b c d e PDB 1FG9; “Observation of an unexpected third receptor molecule in the crystal structure of human interferon-gamma receptor complex”. Structure 8 (9): 927–936. (September 2000). doi:10.1016/S0969-2126(00)00184-2. PMID 10986460.
- ^ “Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases”. Immunity 31 (4): 539–550. (October 2009). doi:10.1016/j.immuni.2009.09.002. PMC 2774226. PMID 19833085 .
- ^ a b “The heparan sulfate binding sequence of interferon-gamma increased the on rate of the interferon-gamma-interferon-gamma receptor complex formation”. The Journal of Biological Chemistry 273 (18): 10919–10925. (May 1998). doi:10.1074/jbc.273.18.10919. PMID 9556569.
- ^ “NMR characterization of the interaction between the C-terminal domain of interferon-gamma and heparin-derived oligosaccharides”. The Biochemical Journal 384 (Pt 1): 93–99. (November 2004). doi:10.1042/BJ20040757. PMC 1134092. PMID 15270718 .
- ^ a b “Interferon-gamma binds to heparan sulfate by a cluster of amino acids located in the C-terminal part of the molecule”. FEBS Letters 280 (1): 152–154. (March 1991). doi:10.1016/0014-5793(91)80225-R. PMID 1901275.
- ^ “Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion”. Frontiers in Immunology 9: 847. (2018). doi:10.3389/fimmu.2018.00847. PMC 5945880. PMID 29780381 .
- ^ “Interferon-gamma: an overview of signals, mechanisms and functions”. Journal of Leukocyte Biology 75 (2): 163–189. (February 2004). doi:10.1189/jlb.0603252. PMID 14525967.
- ^ “The role of cytokines in the regulation of NK cells in the tumor environment”. Cytokine 117: 30–40. (May 2019). doi:10.1016/j.cyto.2019.02.001. PMID 30784898.
- ^ “Tissue-Specific Macrophage Responses to Remote Injury Impact the Outcome of Subsequent Local Immune Challenge”. Immunity 51 (5): 899–914.e7. (November 2019). doi:10.1016/j.immuni.2019.10.010. PMC 6892583. PMID 31732166 .
- ^ “Induction of Autonomous Memory Alveolar Macrophages Requires T Cell Help and Is Critical to Trained Immunity”. Cell 175 (6): 1634–1650.e17. (November 2018). doi:10.1016/j.cell.2018.09.042. PMID 30433869.
- ^ “CD4⁺T cells: differentiation and functions”. Clinical & Developmental Immunology 2012: 925135. (2012). doi:10.1155/2012/925135. PMC 3312336. PMID 22474485 .
- ^ “Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy”. The Journal of Experimental Medicine 192 (2): 259–270. (July 2000). doi:10.1084/jem.192.2.259. PMC 2193246. PMID 10899912 .
- ^ “The role of interferons in early pregnancy”. Gynecological Endocrinology 30 (1): 1–6. (January 2014). doi:10.3109/09513590.2012.743011. PMID 24188446.
- ^ “Effects of products of activated leukocytes (lymphokines and monokines) on the growth of malignant trophoblast cells in vitro”. American Journal of Obstetrics and Gynecology 158 (1): 199–203. (January 1988). doi:10.1016/0002-9378(88)90810-1. PMID 2447775.
- ^ a b “Review of the recombinant human interferon gamma as an immunotherapeutic: Impacts of production platforms and glycosylation”. Journal of Biotechnology 240: 48–60. (December 2016). doi:10.1016/j.jbiotec.2016.10.022. PMID 27794496.
- ^ “Is Pichia pastoris a realistic platform for industrial production of recombinant human interferon gamma?”. Biologicals 45: 52–60. (January 2017). doi:10.1016/j.biologicals.2016.09.015. PMID 27810255 .
- ^ “Interferon gamma-1b. A review of its pharmacology and therapeutic potential in chronic granulomatous disease”. Drugs 43 (1): 111–122. (January 1992). doi:10.2165/00003495-199243010-00008. PMID 1372855.
- ^ “Recombinant human interferon gamma therapy for osteopetrosis”. The Journal of Pediatrics 121 (1): 119–124. (July 1992). doi:10.1016/s0022-3476(05)82557-0. PMID 1320672.
- ^ “The use of interferon-gamma therapy in chronic granulomatous disease”. Recent Patents on Anti-Infective Drug Discovery 3 (3): 225–230. (November 2008). doi:10.2174/157489108786242378. PMID 18991804.
- ^ “Drug Marketing. The line between scientific uncertainty and promotion of snake oil”. BMJ 347: f5687. (September 2013). doi:10.1136/bmj.f5687. PMID 24055923.
- ^ “Statement from the Press Secretary Regarding Executive Grants of Clemency”. whitehouse.gov (2021年1月20日). 2022年4月30日閲覧。
- ^ “IFN-γ for Friedreich ataxia: present evidence”. Neurodegenerative Disease Management 5 (6): 497–504. (December 2015). doi:10.2217/nmt.15.52. PMID 26634868.
- ^ “Open-label pilot study of interferon gamma-1b in Friedreich ataxia”. Acta Neurologica Scandinavica 132 (1): 7–15. (July 2015). doi:10.1111/ane.12337. PMID 25335475.
- ^ “Randomized, double-blind, placebo-controlled study of interferon-γ 1b in Friedreich Ataxia”. Annals of Clinical and Translational Neurology 6 (3): 546–553. (March 2019). doi:10.1002/acn3.731. PMC 6414489. PMID 30911578 .
- ^ “Efficacy and Tolerability of Interferon Gamma in Treatment of Friedreich's Ataxia: Retrospective Study”. Noro Psikiyatri Arsivi 57 (4): 270–273. (December 2020). doi:10.29399/npa.25047. PMC 7735154. PMID 33354116 .
- ^ “Atopic dermatitis: systemic immunosuppressive therapy”. Seminars in Cutaneous Medicine and Surgery 27 (2): 151–155. (June 2008). doi:10.1016/j.sder.2008.04.004. PMID 18620137.
- ^ “Long-term therapy with recombinant interferon-gamma (rIFN-gamma) for atopic dermatitis”. Annals of Allergy, Asthma & Immunology 80 (3): 263–268. (March 1998). doi:10.1016/S1081-1206(10)62968-7. PMID 9532976.
- ^ “Recombinant interferon gamma therapy for atopic dermatitis”. Journal of the American Academy of Dermatology 28 (2 Pt 1): 189–197. (February 1993). doi:10.1016/0190-9622(93)70026-p. PMID 8432915.
- ^ “Recent considerations in the use of recombinant interferon gamma for biological therapy of atopic dermatitis”. Expert Opinion on Biological Therapy 16 (4): 507–514. (2016). doi:10.1517/14712598.2016.1135898. PMC 4985031. PMID 26694988 .
- ^ “Interferon-gamma (IFN-γ): Exploring its implications in infectious diseases”. Biomolecular Concepts 9 (1): 64–79. (May 2018). doi:10.1515/bmc-2018-0007. PMID 29856726.
- ^ “Roles of IFN-γ in tumor progression and regression: a review”. Biomarker Research 8 (1): 49. (2020-09-29). doi:10.1186/s40364-020-00228-x. PMC 7526126. PMID 33005420 .
- ^ “IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer”. British Journal of Cancer 112 (9): 1501–1509. (April 2015). doi:10.1038/bjc.2015.101. PMC 4453666. PMID 25867264 .
- ^ “Improved therapeutic efficacy of mammalian expressed-recombinant interferon gamma against ovarian cancer cells”. Experimental Cell Research 359 (1): 20–29. (October 2017). doi:10.1016/j.yexcr.2017.08.014. PMID 28803068.
- ^ “Observation of an unexpected third receptor molecule in the crystal structure of human interferon-gamma receptor complex”. Structure 8 (9): 927–936. (September 2000). doi:10.1016/S0969-2126(00)00184-2. PMID 10986460.
- ^ “Interaction between the components of the interferon gamma receptor complex”. The Journal of Biological Chemistry 270 (36): 20915–20921. (September 1995). doi:10.1074/jbc.270.36.20915. PMID 7673114.
- ^ “IL18 Gene Variants Influence the Susceptibility to Chagas Disease”. PLOS Neglected Tropical Diseases 10 (3): e0004583. (March 2016). doi:10.1371/journal.pntd.0004583. PMC 4814063. PMID 27027876 .
- ^ “Investigations of seborrheic dermatitis. Part I. The role of selected cytokines in the pathogenesis of seborrheic dermatitis”. Postepy Higieny I Medycyny Doswiadczalnej 66: 843–847. (November 2012). doi:10.5604/17322693.1019642. PMID 23175340.
- ^ “Complexity of Interferon-γ Interactions with HSV-1”. Frontiers in Immunology 5: 15. (2014-02-06). doi:10.3389/fimmu.2014.00015. PMC 3915238. PMID 24567732 .
- ^ “Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus”. The Journal of Cell Biology 136 (5): 1007–1021. (March 1997). doi:10.1083/jcb.136.5.1007. PMC 2132479. PMID 9060466 .
- ^ “Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner”. The Journal of General Virology 91 (Pt 3): 591–598. (March 2010). doi:10.1099/vir.0.016964-0. PMID 19906941.
- ^ “Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1”. Journal of Virology 76 (22): 11541–11550. (November 2002). doi:10.1128/JVI.76.22.11541-11550.2002. PMC 136787. PMID 12388715 .
- ^ “Immune control of herpes simplex virus during latency”. Current Opinion in Immunology 16 (4): 463–469. (August 2004). doi:10.1016/j.coi.2004.05.003. PMID 15245740.
- ^ “The role of IFN-gamma in the outcome of chlamydial infection”. Current Opinion in Immunology 14 (4): 444–451. (August 2002). doi:10.1016/s0952-7915(02)00361-8. PMID 12088678.
- ^ “Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism”. FASEB Journal 5 (11): 2516–2522. (August 1991). doi:10.1096/fasebj.5.11.1907934. PMID 1907934.
- ^ “The p47 GTPases Igtp and Irgb10 map to the Chlamydia trachomatis susceptibility locus Ctrq-3 and mediate cellular resistance in mice”. Proceedings of the National Academy of Sciences of the United States of America 103 (38): 14092–14097. (September 2006). Bibcode: 2006PNAS..10314092B. doi:10.1073/pnas.0603338103. PMC 1599917. PMID 16959883 .
- ^ “Chlamydial IFN-gamma immune evasion is linked to host infection tropism”. Proceedings of the National Academy of Sciences of the United States of America 102 (30): 10658–10663. (July 2005). Bibcode: 2005PNAS..10210658N. doi:10.1073/pnas.0504198102. PMC 1180788. PMID 16020528 .
- ^ “Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR”. Cell 108 (2): 221–232. (January 2002). doi:10.1016/S0092-8674(02)00616-5. PMID 11832212.
- ^ “MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components”. Molecular Immunology 45 (7): 1995–2006. (April 2008). doi:10.1016/j.molimm.2007.10.035. PMC 2678893. PMID 18061676 .
- ^ “Posttranscriptional control of T cell effector function by aerobic glycolysis”. Cell 153 (6): 1239–1251. (June 2013). doi:10.1016/j.cell.2013.05.016. PMC 3804311. PMID 23746840 .
- 1 インターフェロンγとは
- 2 インターフェロンγの概要
- 3 機能
- 4 生産
- 5 相互作用
- 6 調節
- IFN‐γのページへのリンク